Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 4, 2008, Pages 838-844

  Song, Jae Hoon ^a,b   Ko, Kwan Soo ^a,b   Suh, Ji Yoeun ^b   Oh, Won Sup ^a   Kang, Cheol In ^a   Chung, Doo Ryeon ^a   Peck, Kyong Ran ^a   Lee, Nam Yong ^a   Lee, Wee Gyo ^c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^c Ajou University School of Medicine   (South Korea)

Author keywords

Teicoplanin; Vancomycin resistant enterococci; VanD vanA

Indexed keywords

BACTERIAL PROTEIN; PROTEIN VANA; PROTEIN VAND; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; FEMALE; GENETIC ANALYSIS; GENOTYPE; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PERITONITIS; PHENOTYPE; SURVIVAL;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BLOOD; CARBON-OXYGEN LIGASES; COLONY COUNT, MICROBIAL; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PERITONITIS; SURVIVAL ANALYSIS; TEICOPLANIN; VANCOMYCIN RESISTANCE;

EID: 41149084628     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn025     Document Type: Article

References (25)

1. Bonten MJM, Willems R, Weinstein RA. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1: 314-25.
2. Harbarth S, Cosgrove S, Carmell Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant entercocci, Antimicrob Agent Chemother 2002; 46: 1619-28.
3. Lodise TP, Mckinnon PS, Tam VH et al. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant Enterococcus in a level 1 trauma center. Clin Infect Dis 2002; 34: 922-9.
4. Malathum K, Murray BE. Vancomycin-resistant enterococci: Recent advances in genetics, epidemiology and therapeutic options. Drug Resist Updat 1999; 2: 224-43.
5. Woodford N. Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. Microb Drug Resist 2001; 7: 229-34.
6. Cetinkaya Y, Falk P, Mayhal CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000; 13: 686-707.
7. Eom JS, Hwang IS, Hwang BY et al. Emergence of vanA geno-type vancomycin-resistant enterococci with low or moderate levels of teicoplanin resistance in Korea. J Clin Microbiol 2004; 42 1785-6.
8. Hashimoto Y, Tanimoto K, Ozawa Y et al. Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant Enterococcus strains result in high-level vancomycin resistance and low level teicoplanin resistance. FEMS Microbiol Lett 2000; 185: 247-54.
9. Ko KS, Baek JY, Lee JY, et al. Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Korea. J Clin Microbiol 2005; 43: 2303-6.
10. Lauderdale TL, McDonald LC, Shiau YR et al. Vancomycin-resistant enterococci from humans and retail chickens in Taiwan with unique VanB phenotype-vanA genotype incongruence. Antimicrob Agents Chemother 2002; 46: 525-7.
11. Lee WG, Huh JY, Cho SR et al. Reduction in glycopeptide resistance in vancomycin-resistant enterococci as a result of vanA cluster rearrangements. Antimicrob Agents Chemother 2004; 48: 1379-81.
12. Oh WS, Ko KS, Song JH et al. High rate of resistance to quinupristin-dalfopristin in Enterococcus faecium clinical isolates from Korea. Antimicrob Agents Chemother 2005; 49: 5176-8.
13. Song JH, Ko KS, Oh WS et al. High frequency of vancomycin-resistant Enterococcus faecium isolates with VanB phenotype and vanA genotype in Korean hospitals. Diagn Microbiol Infect Dis 2006; 56: 410-06.
14. Naas T, Fortineau N, Sanaoudj R et al. First nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype. J Clin Microbiol 2005; 43: 3642-9.
15. Homan WL, Tribe D, Poznanski S et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 2002; 40: 1963-71.
16. Bell JM, Paton JC, Tumidge J. Emergence of vancomycin-resistant enterococci in Australia: Phenotype and genotype characteristics of isolates. J Clin Microbiol 1998; 36: 2187-90.
17. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S16. CLSI, Wayne, PA, 2006.
18. European Committee on Antimicrobial Susceptibility Testing (EUCAST). European Antimicrobial MIC Breakpoints Through EUCAST and the National Breakpoint Committees. Basel: EUCAST, 2004. http://www.srga.org/ eucastwt/bpsetting.htm (15 November 2007, date last accessed).
19. Huh JY, Lee WG, Lee K et al. Distribution of insertion sequences associated with Tn1546-like elements among Enterococcus faecium isolates from patients in Korea. J Clin Microbiol 2004; 42 1897-902.
20. Peetermans WE, Hoogeterp JJ, Hazekamp-van Dokkum AM et al. Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection. Antimicrob Agents Chemother 1990; 34: 1869-74.
21. Linden PK. Treatment options for vancomycin-resistant enterococcal infections. Drugs 2002; 62: 425-41.
22. Losonsky GA, Wolf A, Schwalbe RS et al. Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents. Clin Infect Dis 1994; 19: 163-5.
23. Baptista M, Depardieu F, Reynolds P et al. Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol Microbiol 1997; 25: 93-105.
24. Lefort A, Garry L, Depardieu F et al. Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium. Antimicrob Agents Chemother 2003; 47: 3515-8.
25. Lefort A, Arthur M, Depardieu F et al. Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis. J Infect Dis 2004; 189: 90-7.